FDA Approves Pfizer, Moderna's Omicron COVID Jabs in Younger KidsZacks Investment Research • 12/09/22
Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of AgeAccesswire • 12/08/22
Moderna Stock Is Yo-Yoing On New Omicron Booster Data — Is It A Buy?Investors Business Daily • 12/07/22
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting historyCNBC • 12/06/22
Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?Zacks Investment Research • 12/06/22
These Are the Five Best and Worst Performing Healthcare Stocks in October 202224/7 Wall Street • 11/29/22
Moderna, Inc. (MRNA) 13th Annual Jefferies London Healthcare Conference 2022 - (Transcript)Seeking Alpha • 11/16/22